[
    {
        "title": "Ameren Corporation - Consensus 'buy' rating and 13.2% Upside ... - DirectorsTalk Interviews",
        "description": "Ameren Corporation - Consensus 'buy' rating and 13.2% Upside ...  DirectorsTalk Interviews",
        "published date": "Thu, 12 Oct 2023 12:12:42 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmRpcmVjdG9yc3RhbGtpbnRlcnZpZXdzLmNvbS9hbWVyZW4tY29ycG9yYXRpb24tY29uc2Vuc3VzLWJ1eS1yYXRpbmctYW5kLTEzLjItdXBzaWRlLXBvdGVudGlhbC0yLzQxMjExMjkzNDbSAQA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.directorstalkinterviews.com",
            "title": "DirectorsTalk Interviews"
        }
    },
    {
        "title": "Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and ... - InvestorPlace",
        "description": "Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and ...  InvestorPlace",
        "published date": "Thu, 27 Jul 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8wNy90b2RheXMtYmlnZ2VzdC1wcmUtbWFya2V0LXN0b2NrLW1vdmVycy0xMC10b3AtZ2FpbmVycy1hbmQtbG9zZXJzLW9uLXRodXJzZGF5LWp1bHktMjd0aC_SAQA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://investorplace.com",
            "title": "InvestorPlace"
        }
    },
    {
        "title": "Lightning Alerts: SOUN, ATER, TMPO, and ATXI - Raging Bull - RagingBull",
        "description": "Lightning Alerts: SOUN, ATER, TMPO, and ATXI - Raging Bull  RagingBull",
        "published date": "Tue, 17 Jan 2023 08:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vcmFnaW5nYnVsbC5jb20vamFzb24tYm9uZC1waWNrcy9saWdodG5pbmctYWxlcnRzLXNvdW4tYXRlci10bXBvLWFuZC1hdHhpL9IBAA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://ragingbull.com",
            "title": "RagingBull"
        }
    },
    {
        "title": "Avenue Therapeutics Announces Pricing of $12 Million Underwritten ... - GlobeNewswire",
        "description": "Avenue Therapeutics Announces Pricing of $12 Million Underwritten ...  GlobeNewswire",
        "published date": "Thu, 06 Oct 2022 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimwFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMi8xMC8wNy8yNTMwMDM5LzAvZW4vQXZlbnVlLVRoZXJhcGV1dGljcy1Bbm5vdW5jZXMtUHJpY2luZy1vZi0xMi1NaWxsaW9uLVVuZGVyd3JpdHRlbi1QdWJsaWMtT2ZmZXJpbmcuaHRtbNIBAA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.globenewswire.com",
            "title": "GlobeNewswire"
        }
    },
    {
        "title": "Avenue Therapeutics Stock Forecast, Price & News (NASDAQ:ATXI) - MarketBeat",
        "description": "Avenue Therapeutics Stock Forecast, Price & News (NASDAQ:ATXI)  MarketBeat",
        "published date": "Tue, 01 Aug 2017 20:58:33 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiLmh0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL3N0b2Nrcy9OQVNEQVEvQVRYSS_SAQA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.marketbeat.com",
            "title": "MarketBeat"
        }
    },
    {
        "title": "Avenue Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) - Yahoo Finance",
        "description": "Avenue Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)  Yahoo Finance",
        "published date": "Thu, 27 Jul 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hdmVudWUtdGhlcmFwZXV0aWNzLWFubm91bmNlcy1maXJzdC1wYXRpZW50LTEyMzAwMDYzNS5odG1s0gFhaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvYXZlbnVlLXRoZXJhcGV1dGljcy1hbm5vdW5jZXMtZmlyc3QtcGF0aWVudC0xMjMwMDA2MzUuaHRtbA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "Avenue Therapeutics Enters into a Transformational License ... - GlobeNewswire",
        "description": "Avenue Therapeutics Enters into a Transformational License ...  GlobeNewswire",
        "published date": "Thu, 02 Mar 2023 08:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi_wFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMy8wMy8wMi8yNjE5MjkzLzAvZW4vQXZlbnVlLVRoZXJhcGV1dGljcy1FbnRlcnMtaW50by1hLVRyYW5zZm9ybWF0aW9uYWwtTGljZW5zZS1BZ3JlZW1lbnQtd2l0aC1Bbm5KaS1QaGFybWFjZXV0aWNhbC10by1EZXZlbG9wLWFuZC1Db21tZXJjaWFsaXplLUFKMjAxLWEtRmlyc3QtaW4tQ2xhc3MtQ2xpbmljYWwtQXNzZXQtZm9yLXRoZS1UcmVhdG1lbnQtLmh0bWzSAQA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.globenewswire.com",
            "title": "GlobeNewswire"
        }
    },
    {
        "title": "Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights - Yahoo Finance",
        "description": "Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights  Yahoo Finance",
        "published date": "Mon, 14 Aug 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9mb3J0cmVzcy1iaW90ZWNoLXJlcG9ydHMtc2Vjb25kLXF1YXJ0ZXItMjAwMTAwMjY0Lmh0bWzSAV1odHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9mb3J0cmVzcy1iaW90ZWNoLXJlcG9ydHMtc2Vjb25kLXF1YXJ0ZXItMjAwMTAwMjY0Lmh0bWw?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://finance.yahoo.com",
            "title": "Yahoo Finance"
        }
    },
    {
        "title": "Avenue Therapeutics Reports Full Year 2022 Financial Results and ... - GuruFocus.com",
        "description": "Avenue Therapeutics Reports Full Year 2022 Financial Results and ...  GuruFocus.com",
        "published date": "Thu, 30 Mar 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigwFodHRwczovL3d3dy5ndXJ1Zm9jdXMuY29tL25ld3MvMTk3MzI3OS9hdmVudWUtdGhlcmFwZXV0aWNzLXJlcG9ydHMtZnVsbC15ZWFyLTIwMjItZmluYW5jaWFsLXJlc3VsdHMtYW5kLXJlY2VudC1jb3Jwb3JhdGUtaGlnaGxpZ2h0c9IBAA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.gurufocus.com",
            "title": "GuruFocus.com"
        }
    },
    {
        "title": "AnnJi Pharmaceutical Announced A Licensing Agreement With ... - BioSpace",
        "description": "AnnJi Pharmaceutical Announced A Licensing Agreement With ...  BioSpace",
        "published date": "Fri, 10 Mar 2023 08:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi4gFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9yZWxlYXNlcy9hbm5qaS1waGFybWFjZXV0aWNhbC1hbm5vdW5jZWQtYS1saWNlbnNpbmctYWdyZWVtZW50LXdpdGgtYXZlbnVlLXRoZXJhcGV1dGljcy10by1kZXZlbG9wLWFuZC1jb21tZXJjaWFsaXplLWFqMjAxLWEtZmlyc3QtaW4tY2xhc3MtY2xpbmljYWwtYXNzZXQtZm9yLXRoZS10cmVhdG1lbnQtb2Yta2VubmVkeS1zLWRpc2Vhc2Uv0gEA?oc%3D5&gl=LT&m=0&pc=n&cm=2&hl=en-US&src=1",
        "publisher": {
            "href": "https://www.biospace.com",
            "title": "BioSpace"
        }
    }
]